Law Offices of Thomas J. Lamb

  • About Firm
  • Practice Areas
  • Free Case Evaluation
  • Quick Contact Form
  • Frequently Asked Questions
  • Attorney Tom Lamb

Ozempic Safety Issues Update: July 2023 Edition

July 20, 2023 By Law Offices of Thomas J. Lamb, P.A.

In this Ozempic safety issues update we report on thyroid cancer, gallbladder disease, and suicidal thoughts as being possible Ozempic side effects. The European Medicines Agency (EMA) recently announced it has begun an investigation into Ozempic and suicidal thoughts as well as self-harm. From July 11, 2023 document “EMA statement on ongoing … [Read more...]

Filed Under: Unsafe Drugs Tagged With: gallbladder disease, gallbladder removal, Ozempic, suicidal ideation, thyroid cancer

Ozempic Gallbladder Cases: Gallbladder Disease and Gallbladder Removal

June 8, 2023 By Law Offices of Thomas J. Lamb, P.A.

The use of Ozempic has been associated with gallbladder diseases such as gallstones (cholelithiasis) and inflammation of the gallbladder (cholecystitis). These Ozempic side effects can lead to gallbladder removal surgery (cholecystectomy). We are currently investigating certain Ozempic gallbladder cases as possible Ozempic drug injury lawsuits that … [Read more...]

Filed Under: Unsafe Drugs Tagged With: gallbladder disease, gallbladder removal, Ozempic

Trulicity Double-Dose Recall in 2021 is Still a Drug Safety Issue in 2023

June 1, 2023 By Law Offices of Thomas J. Lamb, P.A.

There was a relatively “low profile” Trulicity double-dose recall by Eli Lilly & Company back in 2021. Because there may still be thousands of double-dose Trulicity injectors in patients’ homes, we are concerned that this is an ongoing Trulicity drug safety issue. Here are seven reasons why: Some Trulicity autoinjector devices labeled as … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Trulicity

Prolia Side Effect: Hypocalcemia in Patients on Dialysis

May 10, 2023 By Law Offices of Thomas J. Lamb, P.A.

This relatively new Prolia side effect, hypocalcemia, first came to our attention in late 2022 with the release of this November 22, 2022 document, “FDA Drug Safety Communication: FDA investigating risk of severe hypocalcemia in patients on dialysis receiving osteoporosis medicine Prolia (denosumab)”. From that November 2022 FDA Drug Safety … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Hypocalcemia, Prolia

EzriCare Artificial Tears Case Reports Involving Vision Loss

April 14, 2023 By Law Offices of Thomas J. Lamb, P.A.

A recent edition of the JAMA Ophthalmology medical journal presented two EzriCare Artificial Tears case reports about serious infection and vision loss associated with these over-the-counter (OTC) eye drops from Global Pharma. The two EzriCare Artificial Tears case reports are set forth in these March 2023 JAMA Ophthalmology medical journal … [Read more...]

Filed Under: Unsafe Drugs Tagged With: blindness, Delsam Pharma’s Artificial Eye Ointment, Delsam Pharma’s Artificial Tears, EzriCare Artificial Tears, vision loss

EzriCare and Delsam Products Recall: March 2023 Update

March 3, 2023 By Law Offices of Thomas J. Lamb, P.A.

Here is the most recent information from the US Centers for Disease Control and Prevention (CDC) about the EzriCare and Delsam products recall for case reports associated with bacterial contamination: As of March 1, 2023, CDC, in partnership with state and local health departments, identified 64 patients in 13 states (CA, CO, CT, FL, IL, NJ, NM, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Delsam Pharma’s Artificial Eye Ointment, Delsam Pharma’s Artificial Tears, EzriCare Artificial Tears, vision loss

Delsam Pharma Artificial Eye Ointment Recall February 2023

February 24, 2023 By Law Offices of Thomas J. Lamb, P.A.

In late February the FDA announced a Delsam Pharma Artificial Eye Ointment recall by Global Pharma a day after warning not to use this eye product due to a potential Artificial Eye Ointment contamination problem. We are investigating cases involving hospitalization, death, or permanent vision loss from an eye infection due to the Artificial Eye … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Delsam Pharma’s Artificial Eye Ointment, Delsam Pharma’s Artificial Tears, EzriCare Artificial Tears

EzriCare and Delsam Pharma’s Eye Drops Products Recall

February 9, 2023 By Law Offices of Thomas J. Lamb, P.A.

In early February 2023 there was an artificial tears lubricant eye drops products recall involving EzriCare and Delsam Pharma’s Artificial Tears. As a standard practice, when a drug company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. Here is the Global Pharma Healthcare … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Delsam Pharma’s Artificial Tears, EzriCare Artificial Tears, vision loss

EzriCare Artificial Tears Eye Infections Warnings

February 8, 2023 By Law Offices of Thomas J. Lamb, P.A.

There is detailed information about the  in this Centers for Disease Control and Prevention (CDC) Outbreak and Patient Notifications article, “Outbreak of Extensively Drug-resistant Pseudomonas aeruginosa Associated with Artificial Tears”, including this fact: As of January 31, 2023, CDC, in partnership with state and local health departments, … [Read more...]

Filed Under: Unsafe Drugs Tagged With: EzriCare Artificial Tears, vision loss

Valtrex Side Effect: DRESS Skin Reaction, Can be Fatal

December 28, 2022 By Law Offices of Thomas J. Lamb, P.A.

According to the Health Product InfoWatch December 2022 edition released by Health Canada on December 22, 2022, cases of Valtrex-associated DRESS have been reported as a Valtrex side effect. Further, therein, it is reported that GlaxoSmithKline Inc. has updated the Canadian product monograph for Valtrex to add information about the risk of … [Read more...]

Filed Under: Unsafe Drugs Tagged With: Skin Reactions, Valtrex

  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form – it is confidential and there is no obligation.

Or call 910-256-2971 to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

910-256-2971

Main Navigation Menu

  • About Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Lawsuits
  • Breast Implant Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

DrugInjuryLaw.com

DrugInjuryWatch.com

Asbestos-Mesothelioma.com

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2025 · Law Offices of Thomas J. Lamb, P.A.